This invention relates to the use of inhibitorsof VAP-1/SSAO activity, and pharmaceutical compositionscomprising the same, for the treatment of pain; and to acombined preparation comprising an inhibitor of VAP-1/SSAOactivity and a steroid, and the use of the combinedpreparation in medicine, particularly for treatment of pain.